Kyverna Therapeutics
Latest round
- Series B
Last raised
- Aug 2023
Total raised
- $167M
Investors
- 15
About Kyverna Therapeutics
Founded in 2018 by founder Jeffrey Greve, and based in California, US, Kyverna Therapeutics, Inc. is a biotechnology company that operates a cell therapy platform. In October 2025, Kyverna Therapeutics, Inc. The facility includes an initial tranche of USD 40 million and two additional tranches totaling USD 60 million, subject to the satisfaction of certain terms and conditions of the loan and security agreement. A fourth tranche of USD 50 million may also be made available subject to Oxford Finance’s discretion. Kyverna Therapeutics researches and develops cell therapies for patients with autoimmune diseases. As of 2024, the company’s product portfolio includes KYV-101, a CAR (chimeric antigen receptor) T-cell therapy undergoing clinical trials to treat diseases such as multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. The treatment functions by resetting the immune system and targeting B cell-driven haematological malignancies to treat rheumatology and neurology-based autoimmune diseases.
Who invested in Kyverna Therapeutics
15 investors across 3 rounds
See all investors in Kyverna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kyverna Therapeutics
Who invested in Kyverna Therapeutics?
Kyverna Therapeutics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kyverna Therapeutics raised?
Kyverna Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kyverna Therapeutics last raise money?
Kyverna Therapeutics's most recent round on record is a Series B, in Aug 2023.
What does Kyverna Therapeutics do?
Founded in 2018 by founder Jeffrey Greve, and based in California, US, Kyverna Therapeutics, Inc.
Where is Kyverna Therapeutics headquartered?
Kyverna Therapeutics is headquartered in Emeryville, US.
Which VCs invest in companies like Kyverna Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kyverna Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kyverna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.